Calcineurin Splicing Variant Calcineurin Aβ1 Improves Cardiac Function After Myocardial Infarction Without Inducing Hypertrophy
Author(s) -
Leanne E. Felkin,
Takuya Narita,
Renée Germack,
Yasunori Shintani,
Kunihiko Takahashi,
Padmini Sarathchandra,
Marina LópezOlañeta,
Jesús M. Gómez-Salinero,
Ken Suzuki,
Paul J.R. Barton,
Nadia Rosenthal,
Enrique LaraPezzi
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.110.012211
Subject(s) - calcineurin , nfat , pi3k/akt/mtor pathway , protein kinase b , medicine , fibrosis , muscle hypertrophy , microbiology and biotechnology , proinflammatory cytokine , wortmannin , endocrinology , biology , signal transduction , inflammation , transplantation
Calcineurin is a calcium-regulated phosphatase that plays a major role in cardiac hypertrophy. We previously described that alternative splicing of the calcineurin Aβ (CnAβ) gene generates the CnAβ1 isoform, with a unique C-terminal region that is different from the autoinhibitory domain present in all other CnA isoforms. In skeletal muscle, CnAβ1 is necessary for myoblast proliferation and stimulates regeneration, reducing fibrosis and accelerating the resolution of inflammation. Its role in the heart is currently unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom